US Stem Cell had a revenue of 19.97K in the quarter ending Dec 31, 2022, with 40.20%. This bring the company's revenue in the last twelve months to 82.05K, Increased -4.22%. In the fiscal year ending Dec 31, 2022, US Stem Cell had annual revenue of 82.05K with -59.13% growth.